Alkermes plc. (ALKS)

↓ Download CSV

CIK 0001520262 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, Alkermes plc. reported revenue of $1.48B, down 5.2% from the prior year. The company was profitable, with a net margin of 16.4%. It held $2.49B in total assets against $667.70M in total liabilities.

Key ratios (FY2025)

17.2%
Operating margin
16.4%
Net margin
13.3%
Return on equity
-5.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.48B$1.56B$1.66B$1.11B$1.17B$1.04B$1.17B$1.09B$903.37M$745.69M
Cost of Revenue$196.46M$245.33M$253.04M$218.07M$197.32M$178.32M$180.38M$176.42M$154.75M$132.12M
Operating Income$253.96M$420.64M$414.12M-$6.09M$97.75M-$112.43M-$175.48M-$99.13M-$147.90M-$208.66M
Net Income$241.66M$367.07M$355.76M-$158.27M-$48.17M-$110.86M-$196.62M-$139.31M-$157.94M-$208.44M
EPS (Diluted)$1.43$2.17$2.10$-0.97$-0.29$-0.70
Total Assets$2.49B$2.06B$2.14B$1.96B$2.02B$1.95B$1.81B$1.83B$1.80B$1.73B
Total Liabilities$667.70M$590.59M$933.54M$920.23M$911.90M$882.75M$719.96M$653.72M$594.42M$516.94M
Shareholders' Equity$1.82B$1.46B$1.20B$1.04B$1.11B$1.07B$1.09B$1.17B$1.20B$1.21B
Cash & Equivalents$388.57M$291.15M$457.47M$292.47M$337.54M$272.96M$203.77M$266.76M$191.30M$186.38M
Operating Cash Flow$520.75M$439.12M$401.35M$21.04M$101.72M$82.84M$72.08M$99.28M$19.19M-$63.80M
Capital Expenditures$40.42M$33.48M$48.05M$38.26M$28.02M$42.22M$90.94M$69.43M$51.30M$43.66M
Shares Outstanding165.61M162.18M166.98M164.38M161.94M159.16M157.78M155.76M154.01M152.43M